United Therapeutics Corporation (UTHR)

Oncology Corporate Profile

Stock Performance

117.6800
0.2300

3 Month Stock History Chart

HQ Location

1040 Spring Street
Silver Spring, MD 20910

Company Description

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. We have four approved products on the market today and we are not stopping there! From the United States to Europe to the Asia Pacific, we are proud of our multicultural business environment where employees can collaborate with people all over the world. As a group, we are relentless in our pursuit of 'medicines for life' and continue our research into treatments for pulmonary arterial hypertension, cancer, and some of the world's most complicated viral illnesses.

Website: http://www.unither.com

Brand Generic Indication
Unituxin®dinutuximabUnituxin® is an antibody that binds to the surface of neuroblastoma cells. Unituxin is being approved for use as part of a multimodality regimen, including surgery, chemotherapy and radiation therapy for patients who achieved at least a partial response to prior first-line multiagent, multimodality therapy.

This company does not have any pipeline products

Source: http://www.unither.com

Recent News Headlines

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/14/2017 06:20 pm

8/14/2017 06:20 pm

8/14/2017 06:20 am

8/14/2017 06:20 am

8/14/2017 06:20 am

8/12/2017 12:22 pm

8/12/2017 12:22 pm

8/12/2017 12:22 pm

8/12/2017 12:22 pm

8/11/2017 06:20 pm

8/11/2017 06:20 pm

8/11/2017 06:20 pm

8/11/2017 06:20 pm

8/10/2017 12:20 pm

8/10/2017 12:20 pm

8/10/2017 06:20 am

8/9/2017 12:20 pm

8/9/2017 12:20 am

8/4/2017 12:20 pm

8/3/2017 12:20 pm